Cargando…

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine

Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahr, Maximilian, Hiemke, Christoph, Kölle, Markus Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028703/
https://www.ncbi.nlm.nih.gov/pubmed/32116847
http://dx.doi.org/10.3389/fpsyt.2020.00032
_version_ 1783499024512319488
author Gahr, Maximilian
Hiemke, Christoph
Kölle, Markus Alexander
author_facet Gahr, Maximilian
Hiemke, Christoph
Kölle, Markus Alexander
author_sort Gahr, Maximilian
collection PubMed
description Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound, relapse, or recurrence associated with the underlying mental disorder may also occur. The occurrence of obsessive-compulsive symptoms (OCS) following abrupt discontinuation of antidepressants have not yet been reported. Here we report the development of OCS (obsessional suicidal thoughts) in a patient with major depressive disorder and absence of a previous obsessive-compulsive disorder following abrupt discontinuation of venlafaxine. Treatment with escitalopram facilitated remission of OCS. We discuss a possible causal link between abrupt discontinuation of venlafaxine and development of OCS under consideration of pathophysiologic aspects regarding obsessive compulsive disorders, the chronological sequence of symptoms in the present case, and pharmacodynamic and -kinetic aspects. Our case report suggests the possibility of the occurrence of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine.
format Online
Article
Text
id pubmed-7028703
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70287032020-02-28 Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine Gahr, Maximilian Hiemke, Christoph Kölle, Markus Alexander Front Psychiatry Psychiatry Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound, relapse, or recurrence associated with the underlying mental disorder may also occur. The occurrence of obsessive-compulsive symptoms (OCS) following abrupt discontinuation of antidepressants have not yet been reported. Here we report the development of OCS (obsessional suicidal thoughts) in a patient with major depressive disorder and absence of a previous obsessive-compulsive disorder following abrupt discontinuation of venlafaxine. Treatment with escitalopram facilitated remission of OCS. We discuss a possible causal link between abrupt discontinuation of venlafaxine and development of OCS under consideration of pathophysiologic aspects regarding obsessive compulsive disorders, the chronological sequence of symptoms in the present case, and pharmacodynamic and -kinetic aspects. Our case report suggests the possibility of the occurrence of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine. Frontiers Media S.A. 2020-02-12 /pmc/articles/PMC7028703/ /pubmed/32116847 http://dx.doi.org/10.3389/fpsyt.2020.00032 Text en Copyright © 2020 Gahr, Hiemke and Kölle http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Gahr, Maximilian
Hiemke, Christoph
Kölle, Markus Alexander
Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title_full Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title_fullStr Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title_full_unstemmed Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title_short Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
title_sort development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028703/
https://www.ncbi.nlm.nih.gov/pubmed/32116847
http://dx.doi.org/10.3389/fpsyt.2020.00032
work_keys_str_mv AT gahrmaximilian developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine
AT hiemkechristoph developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine
AT kollemarkusalexander developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine